MarginsXMarginsX
Home › Markets › Health Care › GLSI

Greenwich LifeSciences Inc. (GLSI)

GLSI trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$13.76
-7.90% on the day
Market cap
$202.0M
Micro cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerGLSI on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2020
SEC CIK0001799788
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials

Not reported in SEC XBRL data.

Warning signs

Cash runway
8.5 months
$8.9M cash at June 30, 2026
Share count, 1 year
+7.7%
2025-07-28 to 2026-07-24 · +14.2% over 3 years
Going-concern doubt
Yes
10-Q filed August 11, 2026
Insider net buying, 12 months
$586K
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These circumstances raise substantial doubt about the Company's ability to continue as a going concern within one year after the date these financial statements are issued."
10-Q 2026-08-11
Cash and burn$8.9M cash; operating cash flow -$3.1M a quarter.Report 2026-06-30
Shares outstanding14,678,208 (2026-07-24); 13,630,257 a year earlier; 12,848,165 three years earlier.Cover page 2026-07-24
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorMaloneBailey, LLP, Houston, Texas, United States; changed auditors 1 time in 24 months8-K 4.01 2025-07-24
Late filings, 12 months1 NT noticeNT 10-K 2026-03-31
Insider trades, 12 monthsBought $586K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
Not filed-$3.9M-$1.9M$8.9MNo debt tagsNeeds four quarters10-Q 2026-08-11
Q1 2026
2026-03-31
Not filed-$5.7M-$4.7M$10.5MNo debt tagsNeeds four quarters10-Q 2026-08-11
Q4 2025
2025-12-31
Not filed-$9.2M-$3.2M$6.2MNo debt tagsNeeds four quarters10-K 2026-06-01
Q3 2025
2025-09-30
Not filed-$3.7M-$2.7M$3.8MNo debt tagsNeeds four quarters10-K 2026-06-01
Q2 2025
2025-06-30
Not filed-$3.7M-$2.2M$3.1MNo debt tagsNeeds four quarters10-Q 2026-08-11
Q1 2025
2025-03-31
Not filed-$2.7M-$1.8M$2.7MNo debt tagsNeeds four quarters10-Q 2026-08-11
Q4 2024
2024-12-31
Not filed-$9.7M-$1.9M$4.1MNo debt tagsNeeds four quarters10-K 2026-06-01
Q3 2024
2024-09-30
Not filed-$2.7M-$2.6M$5.8MNo debt tagsNeeds four quarters10-Q 2025-11-14

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-32024-10-07
Latest annual report10-K2026-06-01
Latest quarterly / interim10-Q2026-11-16
Latest current report8-K2025-12-18
Latest proxyDEFA14A2026-10-26

Source: SEC EDGAR submissions feed, 280 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-1.5%
1 month-3.6%
3 months-8.8%
Year to date-28.9%
1 year+82.2%
From 52-week high-55.5%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
SIGASIGA Technologies Inc.$2.85+4.01%$204.8M
KROSKeros Therapeutics Inc.$10.03-2.62%$196.8M
CYPHCypherpunk Technologies Inc.$1.93+2.94%$207.4M
NGENNervGen Pharma Corp.$1.82-3.19%$195.9M
TRDAEntrada Therapeutics Inc.$5.00-1.77%$195.8M
YARWYarrow Bioscience Inc.$13.93-22.74%$212.2M
ACIUAC Immune SA$2.09-1.88%$212.7M
VOGXVogenx Inc$14.38-13.74%$213.6M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier